Efficacy of erythroid-stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group

Affiliations

• ¹ Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie Clinique Lyon France.
• ² Sorbonne University, Service de Médecine Interne Hôpital Saint-Antoine, AP-HP Paris France.
• ³ Hématologie Seniors Assistance Publique des Hôpitaux de Paris (APHP) Nord, Hôpital Saint-Louis Université Paris Cité Paris France.
• ⁴ Service de Médecine Interne et Immunologie Clinique IUCT Oncopole, CHU de Toulouse Toulouse France.
• ⁵ Service de Médecine Interne, CHU de Clermont-Ferrand Hôpital Estaing Clermont-Ferrand France.
• ⁶ Department of Internal Medicine Centre Hospitalier du Haut-Anjou Chateau-Gontier France.
• ⁷ Department of Hematology Centre Hospitalier Alpes Lémant Contamine-sur-Arve France.
• ⁸ Service de Médecine Interne, Centre Hospitalier Bourg-en-Bresse Hôpital Fleyriat Bourg-en-Bresse France.
• ⁹ Department of Internal Medicine, AP-HP, Cochin Hospital University of Paris Paris France.
• ¹⁰ Sorbonne University, Department of Internale Medicine Tenon Hospital, AP-HP and ERN RITA Paris France.